 
                                                                                                    08/02/2025
                                            Crizotinib is used to treat non-small cell lung cancer (NSCLC) that is ALK-positive or ROS1-positive. It works by inhibiting the abnormal proteins that promote cancer cell growth.
Key Benefits:
✅ Treats ALK-positive & ROS1-positive NSCLC
✅ Slows tumor growth and prevents spread
✅ Improves survival rates in lung cancer patients
Url- https://www.kasopharmaceuticals.com/
 
 
 
 
                                         
 
                                                                                                     
                                                                                                     
                                                                                                     
                                                                                                     
                                                                                                     
                                                                                                     
                                                                                                     
                                                                                                     
                                                                                                     
                                                                                                     
                                                                                                     
                                         
   
   
   
   
     
   
   
  